Halozyme Therapeutics | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amarin USD 305.2M 156K 2024-09
Amgen USD 33.58B 45M 2025-03
Baxter International USD 683M 0 2024-12
Cytokinetics USD 118K 0 2024-12
DBV Technologies USD 10.98M 1000 2024-09
Eli Lilly USD 592.6M 200K 2025-03
Halozyme Therapeutics USD 123K 4K 2024-12
Indivior 62M 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
MannKind USD 3.03M 276K 2024-12
Pfizer USD 480M 0 2024-12
United Therapeutics USD 800K 0 2025-03



Halozyme Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.